Top Sell
| Security ▼ | Buy | Sell | Buy (1M) | Sell (1M) | Price | Target price | Potential |
|---|---|---|---|---|---|---|---|
| Innate Pharma | 0 | 1 | 0 | 0 | €1.97 | - | - |
| Indivior plc | 0 | 2 | 0 | 0 | €9.10 | €6.00 | -34.066% |
| Glycomimetics Inc. | 3 | 9 | 0 | 2 | €0.14 | €9.13 | 6278.911% |
| Fibrogen Inc. | 0 | 1 | 0 | 0 | €0.35 | - | - |
| Fate Therapeutics Inc. | 3 | 3 | 0 | 0 | €2.90 | €7.31 | 151.996% |
| Evoke Pharma Inc. | 0 | 24 | 0 | 1 | €0.37 | - | - |
| D.Western Therapeutics Institute Inc | 0 | 1 | 0 | 0 | €0.36 | - | - |
| Daiichi Sankyo Co Ltd | 0 | 1 | 0 | 0 | €30.29 | - | - |
| Cytomx Therapeutics Inc | 2 | 1 | 0 | 0 | €1.05 | €50.00 | 4652.852% |
| Cyclacel Pharmaceuticals Inc. | 2 | 10 | 0 | 2 | €0.22 | €14.66 | 6565.591% |
| Corbus Pharmaceuticals Holding Inc. | 1 | 1 | 0 | 0 | €17.50 | €50.00 | 185.714% |
| Compugen Ltd. | 3 | 2 | 0 | 0 | €1.65 | €3.66 | 122.637% |
| Coherus Bioscien. | 1 | 2 | 1 | 0 | €0.95 | - | - |
| Cellectar BioSciences Inc. | 4 | 5 | 0 | 1 | €2.00 | €14.75 | 637.640% |
| Carbylan Therapeutics Inc | 0 | 1 | 0 | 0 | €10.50 | - | - |
| Cara Therapeutics Inc. | 10 | 8 | 0 | 1 | €0.21 | €4.61 | 2089.184% |
| B.R.A.I.N. Biotechnology Research and Information Network AG | 0 | 1 | 0 | 0 | €2.68 | - | - |
| Bluebird Bio Inc. | 7 | 6 | 0 | 0 | €0.51 | €5.47 | 963.403% |
| BioLine RX Ltd ADR | 0 | 1 | 0 | 0 | €0.46 | - | - |
| Biogen Inc. | 55 | 2 | 4 | 0 | €169.15 | €278.47 | 64.630% |
| Biofrontera AG | 0 | 1 | 0 | 0 | €0.33 | - | - |
| Bellicum Pharmaceuticals Inc. | 0 | 10 | 0 | 0 | €0.064 | - | - |
| Bayer AG ADR | 0 | 1 | 0 | 0 | €7.65 | - | - |
| Atara Biotherapeutics Inc. | 1 | 2 | 0 | 0 | €0.37 | - | - |
| Aspira Womens Health Inc. | 1 | 1 | 0 | 0 | €0.73 | €4.99 | 588.607% |